首页> 外国专利> METHOD OF ALLERGEN-SPECIFIC IMMUNOTHERAPY EFFICIENCY EVALUATION APPLIED FOR CHILDREN SUFFERING FROM BRONCHIAL ASTHMA

METHOD OF ALLERGEN-SPECIFIC IMMUNOTHERAPY EFFICIENCY EVALUATION APPLIED FOR CHILDREN SUFFERING FROM BRONCHIAL ASTHMA

机译:支气管哮喘患儿的过敏原特异性免疫治疗效率评估方法

摘要

FIELD: medicine; allergology.;SUBSTANCE: method of allergen-specific immunotherapy efficiency evaluation applied for children implies immune-enzyme analysis for cytokine - TNF-α and IFN-γ in blood serum after 4-week course of allergen-specific immunotherapy followed with calculation of concentration ratio. If ratio value is less or equal to 3.0 immunotherapy is considered to be effective, while coefficient value is more than 3.0 indicates no effect of immunotherapy.;EFFECT: reliable evaluation of allergen-specific immunotherapy efficiency applied for children's bronchial asthma at early stage of therapy to provide well-timed and adequate correction of therapy.;2 ex, 1 tbl
机译:领域:医学;物质:适用于儿童的过敏原特异性免疫疗法效率评估方法意味着针对细胞因子-TNF-α的免疫酶分析。和IFN-γ;过敏原特异性免疫治疗4周疗程后测定血清中的血脂,然后计算浓度比。如果比率值小于或等于3.0,则认为免疫疗法是有效的,而系数值大于3.0则表明免疫疗法无效。;效果:在儿童早期治疗儿童支气管哮喘时,可靠评估过敏原特异性免疫疗法的有效性提供及时,适当的治疗纠正。; 2 ex,1 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号